CHMP published highlights of its April meeting

The Committee for Medicinal Products for Human Use (CHMP) has published the highlights of its most recent meeting held on 18th -21st April 2017.

Eleven medicines were recommended for approval, including four orphans. Two of the orphan medicines (nusinersen and cerliponase alfa) are intended to treat rare neurodegenerative conditions in children.

Click here to see the summary of opinions with full list of approvals, recommendations and withdrawals.